Novel Pharmacological Treatments for Anorexia Nervosa
About this study
Research Team
Professor Jayashri Kulkarni, Dr Eva Gregertsen, Dr Romi Goldschlager
Institution
Monash University
Funding Source
Philanthropy
Project Start Date
1 May 2024
Project End Date
1 May 2027
Participants
Individuals aged 16 and over living with anorexia nervosa (including in partial remission & atypical anorexia nervosa)
What is Involved
5 visits to our research site in Melbourne over a 3 month duration + 1 additional visit 3 months after end of treatment.
Ethics Approval Number
HREC/101711/Alfred-2024
Location
607 St Kilda Road, Melbourne
Contact Details
THRED@monash.edu
The Li-Transformative Hub for Research into Eating Disorders (Li-THRED) at Monash University is conducting a randomised controlled trial to investigate the effects of 3 repurposed medications on anorexia nervosa.
These medications include brexpiprazole, memantine, and zinc. It is hypothesised that these treatments will improve eating disorder symptoms as compared to placebo.
« Back to Browse Resources